NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,627,275 | -10.1% | 25,793 | -10.9% | 0.72% | -8.0% |
| Q2 2023 | $2,921,143 | +3.2% | 28,948 | -5.9% | 0.79% | -0.6% |
| Q1 2023 | $2,829,736 | -1.3% | 30,758 | -2.7% | 0.79% | -3.5% |
| Q4 2022 | $2,867,478 | +11.6% | 31,608 | -6.5% | 0.82% | +7.2% |
| Q3 2022 | $2,569,000 | -10.3% | 33,793 | -0.3% | 0.76% | -1.0% |
| Q2 2022 | $2,865,000 | -4.0% | 33,893 | -0.3% | 0.77% | +11.2% |
| Q1 2022 | $2,983,000 | +0.0% | 33,993 | -0.3% | 0.70% | +3.0% |
| Q4 2021 | $2,982,000 | +7.0% | 34,093 | 0.0% | 0.68% | -2.2% |
| Q3 2021 | $2,788,000 | -10.4% | 34,093 | 0.0% | 0.69% | -10.2% |
| Q2 2021 | $3,111,000 | +5.9% | 34,093 | -0.8% | 0.77% | -1.0% |
| Q1 2021 | $2,938,000 | -11.3% | 34,368 | -2.1% | 0.78% | -21.1% |
| Q4 2020 | $3,314,000 | +10.5% | 35,093 | +1.8% | 0.98% | -8.6% |
| Q3 2020 | $2,999,000 | -2.2% | 34,483 | -1.7% | 1.08% | -1.9% |
| Q2 2020 | $3,065,000 | +5.5% | 35,093 | -0.4% | 1.10% | -6.6% |
| Q1 2020 | $2,905,000 | -14.3% | 35,228 | -1.6% | 1.17% | +22.9% |
| Q4 2019 | $3,390,000 | +5.6% | 35,803 | -3.0% | 0.96% | -0.7% |
| Q3 2019 | $3,209,000 | -5.1% | 36,923 | -0.2% | 0.96% | -5.1% |
| Q2 2019 | $3,380,000 | -5.5% | 37,013 | -0.5% | 1.01% | -4.1% |
| Q1 2019 | $3,575,000 | +6.5% | 37,183 | -5.0% | 1.06% | -3.6% |
| Q4 2018 | $3,358,000 | -2.5% | 39,133 | -2.1% | 1.10% | +16.3% |
| Q3 2018 | $3,443,000 | +13.7% | 39,965 | -0.2% | 0.94% | +7.8% |
| Q2 2018 | $3,027,000 | -10.5% | 40,065 | -4.2% | 0.88% | -8.4% |
| Q1 2018 | $3,381,000 | -3.8% | 41,815 | -0.1% | 0.96% | -2.5% |
| Q4 2017 | $3,514,000 | -4.8% | 41,853 | -2.6% | 0.98% | -5.8% |
| Q3 2017 | $3,691,000 | +1.5% | 42,990 | -1.4% | 1.04% | -2.3% |
| Q2 2017 | $3,638,000 | +8.9% | 43,590 | -3.1% | 1.06% | +4.6% |
| Q1 2017 | $3,340,000 | +1.8% | 44,965 | -0.2% | 1.02% | +0.2% |
| Q4 2016 | $3,281,000 | -7.7% | 45,040 | 0.0% | 1.01% | -11.7% |
| Q3 2016 | $3,556,000 | -5.1% | 45,040 | -0.8% | 1.15% | -9.7% |
| Q2 2016 | $3,746,000 | +12.2% | 45,405 | -1.5% | 1.27% | +13.6% |
| Q1 2016 | $3,340,000 | -19.0% | 46,105 | -3.8% | 1.12% | -21.6% |
| Q4 2015 | $4,123,000 | -6.4% | 47,915 | 0.0% | 1.43% | -8.6% |
| Q3 2015 | $4,404,000 | -6.8% | 47,915 | -0.3% | 1.56% | +3.8% |
| Q2 2015 | $4,727,000 | -2.1% | 48,070 | -1.8% | 1.51% | -2.7% |
| Q1 2015 | $4,828,000 | +0.1% | 48,965 | -5.9% | 1.55% | -0.5% |
| Q4 2014 | $4,822,000 | -1.8% | 52,040 | -0.2% | 1.56% | -9.7% |
| Q3 2014 | $4,910,000 | +3.6% | 52,165 | -0.4% | 1.72% | +10.3% |
| Q2 2014 | $4,741,000 | +5.1% | 52,365 | -1.3% | 1.56% | +0.5% |
| Q1 2014 | $4,512,000 | +4.7% | 53,065 | -1.0% | 1.55% | +15.1% |
| Q4 2013 | $4,308,000 | +4.6% | 53,590 | -0.1% | 1.35% | +1.0% |
| Q3 2013 | $4,117,000 | +8.3% | 53,665 | -0.1% | 1.34% | +2.1% |
| Q2 2013 | $3,800,000 | – | 53,740 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |